Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›NOI - Olink Explore HT Proteomic Analysis for Sepsis…

U.S. Department Of Health And Human Services·Maryland

NOI - Olink Explore HT Proteomic Analysis for Sepsis Biomarker Study

Closes 5/13/2026$100k – $500kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Heart, Lung, and Blood Institute (NHLBI) intends to award a non-competitive purchase order for high-throughput proteomic analysis services using the Olink Explore HT platform. The requirement involves analysis of plasma samples from a non-human primate septic shock model to support research on inflammatory biomarkers and therapeutic response. The contractor shall provide sample processing, assay execution, quality control, and delivery of normalized, analysis-ready datasets. Some key points to consider are: * The contractor must have the ability to perform large-scale (>5,400 proteins) NGS-based proteomic analysis with the required sensitivity, reproducibility, and compatibility with existing datasets. * The contractor must provide sample processing, assay execution, quality control, data normalization, and delivery of complete, analysis-ready datasets. * The contractor must have experience with the Olink Explore HT platform and Next Generation Sequencing (NGS)-based readout. * The contractor must be able to deliver the services within the required timeframe and meet the technical requirements specified in the solicitation.

Attached files

Contact

Nicholas Capobianco(Contract Specialist)

[email protected]

(100) 000-0000

Key dates

Opened
4/29/2026
Closes
5/13/2026

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
541380
Solicitation №
75N98026Q00280

Budget estimate

$100,000 – $500,000

The budget for this opportunity is not explicitly stated, but based on the complexity and scope of the project, it is likely to be in the range of $100,000 to $500,000. The factors that may influence the likely payment range include the cost of the Olink Explore HT platform, the cost of sample processing and assay execution, and the cost of data normalization and delivery. Additionally, the contractor's experience and reputation in the field of proteomic analysis may also impact the payment amount.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 65%

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

64% match

Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases

Closes 1/21/2027Opened 6/24/2026

U.S. Department Of Health And Human Services·Maryland

64% match

NIA:Non-Competitive Combined Synopsis/Solicitation

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

64% match

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Closes 6/7/2027Opened 8/20/2026

U.S. National Institutes of Health·United States of America

64% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. Department Of Health And Human Services·Maryland

64% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. Department Of Health And Human Services·Indiana

63% match

NOI - B2B Award entitled - Developing Red Cell-Sp

Closes 11/4/2026Opened 10/20/2026

U.S. National Institutes of Health·United States of America

63% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

63% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. Department Of Health And Human Services·Maryland

63% match

NOI - DNA Sequencing of Bone Marrow Failure Syndro

Closes 11/2/2026Opened 10/22/2026

U.S. National Institutes of Health·United States of America

63% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

63% match

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. Department Of Veterans Affairs·Florida

63% match

6632--FY27 Microbial Incubation ID and Susceptibility CPT

Closes 11/10/2026Opened 10/27/2026

U.S. Department Of Defense·Virginia

63% match

High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)

Closes 11/5/2026Opened 10/8/2026

U.S. National Institutes of Health·United States of America

62% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. National Institutes of Health·United States of America

62% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

Iowa State University·Iowa

62% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. National Institutes of Health·United States of America

62% match

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 10/28/2024

U.S. National Institutes of Health·United States of America

62% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

62% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

62% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

62% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

62% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

62% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025